Literature DB >> 11223536

A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.

J Dohnálek 1, J Hasek , J Dusková , H Petroková , M Hradilek , M Soucek , J Konvalinka , J Brynda , J Sedlácek , M Fábry .   

Abstract

Crystallization conditions for an HIV-1 protease-inhibitor complex were optimized to produce crystals suitable for X-ray diffraction experiments. The X-ray structure of the HIV-1 protease complex was solved and refined at 3.1 A resolution. In contrast to Saquinavir, the mimetic hydroxy group of the inhibitor Boc-Phe-Psi[(S)-CH(OH)CH(2)NH]-Phe-Glu-Phe-NH(2) is placed asymmetrically with respect to the non-crystallographic twofold axis of the protease dimer so that hydrogen bonds between the amino group of the inhibitor and the catalytic aspartates can be formed. The inhibitor binds in the centre of the active site by a compact network of hydrogen bonds to Gly27, Gly127, Asp25, Asp125 and via the buried water molecule W301 to Ile50 and Ile150.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223536     DOI: 10.1107/s0907444900018928

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  2 in total

1.  Inhibition and substrate recognition--a computational approach applied to HIV protease.

Authors:  H M Vinkers; M R de Jonge; E D Daeyaert; J Heeres; L M H Koymans; J H van Lenthe; P J Lewi; H Timmerman; P A J Janssen
Journal:  J Comput Aided Mol Des       Date:  2003-09       Impact factor: 3.686

2.  On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data.

Authors:  Paul J Lewi; Marc de Jonge; Frits Daeyaert; Luc Koymans; Maarten Vinkers; Jan Heeres; Paul A J Janssen; Eddy Arnold; Kalyan Das; Art D Clark; Stephen H Hughes; Paul L Boyer; Marie-Pierre de Béthune; Rudi Pauwels; Koen Andries; Mike Kukla; Donald Ludovici; Bart De Corte; Robert Kavash; Chih Ho; Paul J Lewis
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.